Basics Phathom Pharmaceuticals, Inc. IPO Date: October 21, 2019 Sector: Healthcare Industry: Biotech Market Cap: $993.92M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.61% Avg Daily Range (30 D): $0.39 | 3.26% Avg Daily Range (90 D): $0.33 | 3.15% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): 1.01M Avg Daily Volume (90 D): 1.05M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 788 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $1.75M Avg Inst. Trade (90 D): $1.59M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.41M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.1M Avg Closing Volume: 103.41K     News Oct 20, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Third Quarter 20... Source: Phathom Pharmaceuticals Aug 20, 2025 @ 12:00 PM Phathom Pharmaceuticals Clarifies That There Is No... Source: Nick Benedetto Jul 28, 2025 @ 12:00 PM Phathom Pharmaceuticals to Report Second Quarter 2... Source: Phathom Pharmaceuticals Apr 16, 2025 @ 12:00 PM Phathom Pharmaceuticals Appoints Ted Schroeder to ... Source: N/A Apr 1, 2025 @ 12:00 PM Phathom Pharmaceuticals Announces Leadership Succe... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.68 $-1.05 $-1.31 Diluted EPS $-4.68 $-1.05 $-1.31 Revenue $ 114.04M $ 39.5M $ 28.52M Gross Profit $ 99.11M $ 34.47M $ 24.8M Net Income / Loss $ -330.15M $ -75.81M $ -94.32M Operating Income / Loss $ -269M $ -59.92M $ -78.86M Cost of Revenue $ 14.93M $ 5.04M $ 3.72M Net Cash Flow $ -126.67M $ -147.69M $ M PE Ratio